Cargando…

Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease

People across the world are affected by the "coronavirus disease 2019 (COVID-19)", brought on by the "SARS-CoV type-2 coronavirus". Due to its high incidence in individuals with diabetes, metabolic syndrome, and metabolic-associated fatty liver disease (MAFLD), COVID-19 has gaine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeeyavudeen, Mohammad Sadiq, Chaudhari, Rahul, Pappachan, Joseph M, Fouda, Sherouk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850935/ https://www.ncbi.nlm.nih.gov/pubmed/36688018 http://dx.doi.org/10.3748/wjg.v29.i3.487

Ejemplares similares

Management of metabolic-associated fatty liver disease: The diabetology perspective
por: Jeeyavudeen, Mohammad Sadiq, et al.
Publicado: (2023)

Individualized diabetes care: Lessons from the real-world experience
por: Khor, Xiao Ying, et al.
Publicado: (2023)

Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update
por: Fouda, Sherouk, et al.
Publicado: (2022)

Metabolic complications of hepatitis C virus infection
por: Chaudhari, Rahul, et al.
Publicado: (2021)

Implications of metabolic dysfunction associated fatty liver disease in COVID-19
por: Chakraborty, Raja, et al.
Publicado: (2023)

Management of diabesity: Current concepts
por: Michaelidou, Maria, et al.
Publicado: (2023)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

COVID-19 and pediatric fatty liver disease: Is there interplay?
por: Di Sessa, Anna, et al.
Publicado: (2021)

Is Type 2 Diabetes Mellitus a Behavioural Disorder? An Evidence Review for Type 2 Diabetes Mellitus Prevention and Remission through Lifestyle Modification
por: Li, Matthias, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
por: Ahmed, Musaab, et al.
Publicado: (2021)

Sex dimorphism and metabolic profiles in management of metabolic-associated fatty liver disease
por: Martin-Grau, Maria, et al.
Publicado: (2023)

Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
por: Gill, Madeleine G, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
por: Dietrich, Christoph G, et al.
Publicado: (2023)

De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
por: Han, Ma Ai Thanda, et al.
Publicado: (2021)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
por: Vasques-Monteiro, Isabela Macedo Lopes, et al.
Publicado: (2021)

Diabetes and cognitive function: An evidence-based current perspective
por: Sebastian, Meghna Julian, et al.
Publicado: (2023)

Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
por: Anirvan, Prajna, et al.
Publicado: (2021)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions
por: Lanzaro, Francesca, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
por: Pal, Shreya C, et al.
Publicado: (2023)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Fatty liver and celiac disease: Why worry?
por: Narciso-Schiavon, Janaina Luz, et al.
Publicado: (2023)

Prevention, diagnostic evaluation, management and prognostic implications of liver disease in critically ill patients with COVID-19
por: Valsamaki, Asimina, et al.
Publicado: (2023)

Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
por: Fassio, Eduardo, et al.
Publicado: (2022)

Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2022)

Impact of COVID-19 on liver disease: From the experimental to the clinic perspective
por: Gato, Sheila, et al.
Publicado: (2021)

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017)

Statin-related Muscle Toxicity: An Evidence-based Review
por: Jeeyavudeen, Mohammad S, et al.
Publicado: (2022)

Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Liver and COVID-19: From care of patients with liver diseases to liver injury
por: Gaspar, Rui, et al.
Publicado: (2021)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Associations between nonalcoholic fatty liver disease and ischemic stroke
por: Alkagiet, Stelina, et al.
Publicado: (2018)

Obese children with fatty liver: Between reality and disease mongering
por: Ranucci, Giusy, et al.
Publicado: (2017)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021)

Emerging role of engineered exosomes in nonalcoholic fatty liver disease
por: Ding, Jian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_145okml80uc03d0p6r4u9f0sbm